News

EP PerMed - New Fast Track and Venture Creator Programmes

Published on | 11 months ago

Programmes Health

The European Partnership for Personalised Medicine (EP PerMed) introduces two new opportunities for start-ups, researchers, and early-stage teams working on cutting-edge solutions in personalised medicine. These programmes aim to accelerate the development, validation, and market readiness of transformative innovations that enhance patient care:

  • Fast Track Validation Programme 
    Designed to address a critical bottleneck in personalised medicine development, this programme supports validation studies to elevate projects to higher technological and market readiness levels.
    Join the info webinar on 21 January 2025 here

  • Ventior Creation Programme
    This programme empowers early-stage ventures or teams in personalised medicine by bridging the gap between innovation and commercialisation through mentoring, business model development, and customer discovery.
    Join the info webinar on 28 January 2025 here

Submission deadline is 13 March 2025

Find out more
about both calls and how to apply on the EP PerMed website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1753 articles available search in articles 

Testimonial

image of Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.

ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.